ClinVar Miner

Submissions for variant NM_018006.5(TRMU):c.1106C>T (p.Ala369Val)

gnomAD frequency: 0.00016  dbSNP: rs111608902
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000200577 SCV000252413 uncertain significance not provided 2021-09-02 criteria provided, single submitter clinical testing In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 27535533)
Invitae RCV000200577 SCV002155999 uncertain significance not provided 2022-08-13 criteria provided, single submitter clinical testing This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 369 of the TRMU protein (p.Ala369Val). This variant is present in population databases (rs111608902, gnomAD 0.08%). This variant has not been reported in the literature in individuals affected with TRMU-related conditions. ClinVar contains an entry for this variant (Variation ID: 215290). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TRMU protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Ambry Genetics RCV003165458 SCV003874259 uncertain significance Inborn genetic diseases 2023-03-06 criteria provided, single submitter clinical testing The c.1106C>T (p.A369V) alteration is located in exon 11 (coding exon 11) of the TRMU gene. This alteration results from a C to T substitution at nucleotide position 1106, causing the alanine (A) at amino acid position 369 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Natera, Inc. RCV001833156 SCV002076164 uncertain significance Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins 2019-11-11 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.